honokiol has been researched along with Respiratory Distress Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Li, W; Lu, L; Qi, D; Wang, D; Zhang, Z | 1 |
1 other study(ies) available for honokiol and Respiratory Distress Syndrome
Article | Year |
---|---|
Honokiol protects pulmonary microvascular endothelial barrier against lipopolysaccharide-induced ARDS partially via the Sirt3/AMPK signaling axis.
Topics: AMP-Activated Protein Kinase Kinases; Angiopoietin-2; Animals; Apoptosis; Biphenyl Compounds; Capillary Permeability; Case-Control Studies; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Humans; Lignans; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Protein Kinases; Respiratory Distress Syndrome; Signal Transduction; Sirtuin 3 | 2018 |